Literature DB >> 19493068

Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules.

Kristina M Lybecker1, Elisabeth Fowler.   

Abstract

This paper examines two recent examples of compulsory licensing legislation: one globally embraced regime and one internationally controversial regime operating under the same WTO rules. In particular, we consider Canadian legislation and the use of compulsory licensing for HIV/AIDS drugs destined for a developing country. This is then contrasted with the conditions under which Thai authorities are pursuing compulsory licenses, the outcomes of their compulsory licenses, as well as the likely impact of the Thai policy. Finally, we construct a rubric to evaluate characteristics of a successful regime. This is used to analyze the Canadian and Thai regimes and frame the expected implications of each national policy. It is hoped that the assessment will guide changes to compulsory licensing design to ensure that legitimate regimes are embraced while illegitimate ones are disallowed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19493068     DOI: 10.1111/j.1748-720X.2009.00367.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  6 in total

1.  Using TRIPS flexibilities to facilitate access to medicines.

Authors:  Dianne Nicol; Olasupo Owoeye
Journal:  Bull World Health Organ       Date:  2013-04-18       Impact factor: 9.408

2.  Compulsory licensing and access to drugs.

Authors:  Charitini Stavropoulou; Tommaso Valletti
Journal:  Eur J Health Econ       Date:  2014-01-10

Review 3.  Scaling up chronic disease prevention interventions in lower- and middle-income countries.

Authors:  Thomas A Gaziano; Neha Pagidipati
Journal:  Annu Rev Public Health       Date:  2013-01-07       Impact factor: 21.981

Review 4.  Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition.

Authors:  Dorairaj Prabhakaran; Shuchi Anand; David Watkins; Thomas Gaziano; Yangfeng Wu; Jean Claude Mbanya; Rachel Nugent
Journal:  Lancet       Date:  2017-11-03       Impact factor: 79.321

5.  Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.

Authors:  Kyung-Bok Son
Journal:  Global Health       Date:  2019-06-27       Impact factor: 4.185

6.  Health and health-care systems in southeast Asia: diversity and transitions.

Authors:  Virasakdi Chongsuvivatwong; Kai Hong Phua; Mui Teng Yap; Nicola S Pocock; Jamal H Hashim; Rethy Chhem; Siswanto Agus Wilopo; Alan D Lopez
Journal:  Lancet       Date:  2011-01-29       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.